MedPage Today on MSN
New TYK2 inhibitors for psoriasis achieve high clearance rates in randomized trials
Three-fourths of patients have 70-75% improvement at 16 weeks with zasocitinib, envudeucit ...
Aroa Biosurgery Limited today announced completion of its randomised controlled trial (RCT) evaluating Symphony, with a preliminary study read-out indicating the trial ...
Clinical Trials Arena on MSN
AstraZeneca reports positive data from phase III trial of efzimfotase alfa
The programme enrolled 196 children, adolescents, and adults with either paediatric-onset or adult-onset HPP.
Whole-blood transfusion has recently gained favor in the management of severe hemorrhage; however, data from large clinical trials evaluating its clinical effectiveness and safety are lacking. We ...
BACKGROUND: Medically tailored meals (MTM) have unanswered implementation questions. Providing MTM for a specific individual, ...
Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET) The median time post-HCT was ...
Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial Patients with advanced lung cancer reporting at least moderate ...
LifeNet Health, a global leader in regenerative medicine, has received the Best Randomized Controlled Trial Award at the 2026 CAMPs Awards for its Matrion® diabetic foot ulcer study. In this ...
Clinical trials are losing participants. Patient-first design and decentralized models can help fix the dropout problem.
Aroa Biosurgery Limited today announced completion of its randomised controlled trial (RCT) evaluating Symphony ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results